Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017.

Anna K Langenbruch Nicole Zander Natalia Kirsten Kristian ReichR von KiedrowskiK StrömerUlrich Mrowietz Matthias Augustin

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)

A remarkable improvement in the health care quality for psoriasis patients in Germany within the past 12 years can be assumed. Major determinants could be the innovation shift which included programmes such as the S3 guideline, a consensus on treatment goals, national health care goals for psoriasis and higher utilisation of innovative drugs.

Keyphrases

healthcare
quality improvement
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
affordable care act
palliative care
global health
patient reported outcomes
clinical practice
public health
pain management